MSD’s PD-1 inhibitor Keytruda has been approved by the FDA as a treatment for locally advanced unresectable or metastatic biliary tract cancer (BTC) in combination with chemotherapy, the first ...

inoperable biliary tract cancer," Shroff said. "Our research also indicates that the three-drug regimen may increase the toxicity of the treatment." Shroff noted that the three-drug regimen might ...

Biliary tract cancer occurs in the bile ducts and gallbladder, with approximately 23,000 diagnoses in the US each year. Life expectancy is poor, with just 5% to 15% of patients expected to live ...

inoperable biliary tract cancer,” Shroff said. “Our research also indicates that the three-drug regimen may increase the toxicity of the treatment.” Shroff noted that the three-drug regimen ...

inoperable biliary tract cancer," Shroff said. "Our research also indicates that the three-drug regimen may increase the toxicity of the treatment." Shroff noted that the three-drug regimen might ...

The outlook for people with biliary tract cancers is often poor, because they are typically diagnosed late, with few treatment options other than chemotherapy Dr Tayyaba Jiwani, Cancer Research UK ...

Some people on the drugs have seen their cancer ... treatment. Overall, the study aims to recruit 800 people from all over the world. Bile duct cancer (also called cholangiocarcinoma or biliary ...